Некоторые факторы неблагоприятного прогноза на один год у пациентов с фибрилляцией предсердий

The aim of the study to determine factors of unfavorable influence on 12-months prognosis of life of patients with atrial fibrillation. Materials and methods of the study: The study included 183 patients (52.5% men) with atrial fibrillation (AF), with an average age of 66.2±10.0 years. Results of the study: It was found that 36% of patients had paroxysmal AF, 16% had persistent AF, and 48% had permanent AF. Non-valvular etiology of AF was identified in 85.3% of patients. Initially, 22% of patients were taking warfarin, while 37% were taking novel oral anticoagulants (NOACs). Based on the results of the one-year follow-up, patients were divided into two groups: group 1 with a favorable outcome (n=156) and group 2 (n=27) with an unfavorable outcome (total of 15 deaths, of which 11 were due to cardiovascular causes, including 6 cases of sudden death, 5 cases of chronic heart failure (CHF) decompensation requiring rehospitalization, 3 cases of ischemic stroke, including 1 fatal, and 4 cases of bleeding). Conclusion: A low initial rate of anticoagulant use was identified – 59%, including NOACs in 37%. High overall mortality (8.2%) and cardiovascular mortality (6.0%) were observed among AF patients over 12 months. Overall, an unfavorable prognosis was seen in 14.8% of patients.